JunckL.MarshallW.H., Neurotoxicity of radiological contrast agents, Ann. Neurol., 13:469–484, 1983.
2.
VincenF.M.ZimmermanJ.E., Metrizamide encephalopathy, Ann. Neurol., 7:494, 1980.
3.
VollmerM.E., Prolonged confusion due to absence status following metrizamide myelography, Arch. Neurol., 43:1005, 1985.
4.
HauserW.A., Status epilepticus: Frequency, etiology, and neurological sequelae, Adv. Neurol, 34:3–14, 1983.
5.
NorthingtonJ.W.BieryD.N.GlickmanL.T., Intrathecal dextrose to prevent seizures after metrizamide myelography in dogs, Invest. Radiol., 17:282–283, 1982.
6.
RusselD.AnkeI.M.Nyberg-HansenR., Complex partial status epilepticus following metrizamide myelography, Ann. Neurol., and8:325–327, 1980.
7.
AndermannF.RobbJ.P., Absence status: A reappraisal following review of 38 patients, Epilepsia, 13:177–187, 1972.
8.
GubermannA., Nonconvulsive generalized status epilepticus: Clinical features, neuropsychological testing and longterm followup, Neurol., 36:1284–1291, 1986.
9.
FinchamR.W.YamadaT.SchotteliusD.D.HayrehS.M.S.DamasioA., Electroencephalographic absence status with minimal behavior change, Arch. Neurol., 36:176–178, 1979.
10.
CummingsJ.L.BensonD.F., Sub-cortical dementia: Review of an emerging concept, Arch. Neurol., 41:874–879, 1984.
11.
RichardP.BrennerR.P., Absence status: Case reports and a review of the literature, L'Encéphale, 6:385–392, 1980.
12.
NiedermeyerE.KhalifehR., Petit mal status (“spike-wave stupor”): An electro-clinical appraisal, Epilepsia, 6:250–262, 1965.
13.
LugaresiE.PazzagliaP.TassinariC.A., Differentiation of “absence status” and “temporal lobe status,”Epilepsia, 12:77–87, 1971.
14.
RumplE.HinterhuberH., Unusual “spike-wave stupor” in a patient with manic-depressive psychosis treated with amitriptyline, J. Neurol., 226:131–135, 1981.
15.
TreimanD.M.Delgado-EscuetaA.V., Complex partial status epilepticus: In: Delgado-EscuetaA.V.WasterlainC.G.TreimanD.M.PorterR.J., Eds., Status Epilepticus. Advances in Neurology, Vol. 34, New York, Raven Press, pp. 69–81, 1983.